Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

STRIDES PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

AVANTHI INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 55
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 55
  • 0 comments

FDA approve ETODOLAC

Comment Full text

AIPING PHARM INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 60
  • 0 comments

FDA approve MELOXICAM

Comment Full text

DR REDDYS LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve MELOXICAM

Comment Full text

ESJAY PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve MELOXICAM

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 53
  • 0 comments

FDA approve MELOXICAM

Comment Full text

CIPLA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve MELOXICAM

Comment Full text

DR REDDYS LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 42
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 41
  • 0 comments

FDA approve ETODOLAC

Comment Full text
  • Previous
  • 295
  • 296
  • 297
  • 298
  • 299
  • Next

Search

News categories

  • Technical Exchange News(12372)
  • Event(6229)
  • SEC News(272503)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158356)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin